It has given the Massachusetts Institute of Technology Scientists a new tool for fighting bacteria resistant to antibiotics

Dangerous antibiotics bacteria are dangerous because they “already know” what most antibiotics look. Scientists at the Massachusetts Institute of Technology I have found a way to create something new: the use of obstetric intelligence to design antibiotic compounds from scratch can kill drug -resistant gonorrhea and MRSA in laboratory and mice dishes.

Antibiotics resistance is one of the largest general health threats in the world, but new antibiotics have been rare for decades. Traditional drug discovery methods depend on the examination of well -known chemical libraries – a slow process with a limited group of existing molecules. On the contrary, the MIT AI system has generated more than 36 million theoretical compounds, unprecedented by chemical structures before, and unprecedented on two of the most prominent. Both are not different from any antibiotics currently in use, which provides a glimpse of how to overcome artificial intelligence beyond accelerating research to imagine drugs that may be impossible to find otherwise.

“Through adventure in unstable areas of chemical space, our goal was to discover new work mechanisms,” said Arte Krishnan, the Massachusetts Institute of Technology on the crisis of antimicrobial resistance in a different way.

Also read: Do you really learn when you use artificial intelligence? What researchers found the Massachusetts Institute of Technology

How was the science withdrawn

The Massachusetts Institute of Technology team exceeded the restrictions imposed on examining the current chemical libraries by asking artificial intelligence to invent molecules from the zero point, which led to the generation of more than 36 million theoretical vehicles, which were then narrowed to a few laboratories against drug -resistant great greats.

This involves two strategies that move AI:

Fragments -based design: Artificial intelligence began with a chemical fragment (named F1), which showed a promise against gonorrhea. Millions of derivatives, eventually produced a brief list of about 1,000 candidates. Of the 80 researchers, NG1 has emerged as a prominent compound that successfully treated drug -resistant gonorrhea in cell cultures and mouse.

Unrestricted generation: The team allowed to wander freely, and the design of molecules on its own, with the goal of MRSA. This produced more than 29 million candidates, which were nominated to 90 vehicles for a synthesis. Twenty -two were produced, six performed well in laboratory tests and one in particular, DN1, are able to get rid of MRSA infections in mice.

NG1 and DN1 are structurally different from any antibiotics currently known and seem to destroy bacteria by disrupting cell membranes. NG1 specifically targets LPTA, which is a formerly exploited bacterial protein that participates in building the outer cell membrane.

What is the next to search for antibiotics

Phene Bio, a non-profit organization in the AI-AI project, improves NG1 and DN1 to improve their drug properties, while researchers enrich the platform of artificial intelligence to target other difficult pathogens such as tuberculosis (pre-factor for tuberculosis) and Pseudomonas Aeruginosa (a group of publications often.

The study, published for the first time in MagazineIt indicates an optimistic shift in the global struggle against Superbugs.

However, these results are the early stage. Initial tests and laboratory results are encouraging, but human safety and effectiveness must be created by improving a strict laboratory and clinical experiences, a process that may extend for several years.

This effort depends on the Massachusetts Institute of Technology in the development of AI’s antibiotics, including HalisinDiscover in 2020 through deep learning, and AposinIt was discovered in 2023 via the machine learning algorithm.

Read more: Artificial Intelligence Basics: 29 ways to make Gen AI work for you, according to our experts